prkaca Protein

📖 Wiki Page

protein1158 wordssynced 2026-04-02

Protein Kinase CAMP-Activated Catalytic Subunit Alpha (PKA Cα)

Introduction

Prkaca Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@adams1992]
<table> [@wang2003]
<tr><th colspan="2" style="background:#f0f0f0; text-align:center;">PKA Catalytic Subunit Alpha</th></tr> [@noble2005]
<tr><td><b>Gene Symbol</b></td><td><a href="/genes/prkaca">PRKACA</a></td></tr>
<tr><td><b>UniProt ID</b></td><td><a href="https://www.uniprot.org/uniprot/P17612">P17612</a></td></tr>
<tr><td><b>PDB ID</b></td><td>1J3H, 2GU8, 3TNP</td></tr>
<tr><td><b>Molecular Weight</b></td><td>40.6 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Cytosol, nucleus, plasma membrane</td></tr>
<tr><td><b>Protein Family</b></td><td>Protein kinase A (PKA) family, cAMP-dependent protein kinase</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a>, <a href="/wiki/hypertension" style="color:#ef9a9a">Hypertension</a>, <a href="/wiki/infection" style="color:#ef9a9a">Infection</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">64 edges</a></td>
</tr>
</table>
</div>

Overview

...

Protein Kinase CAMP-Activated Catalytic Subunit Alpha (PKA Cα)

Introduction

Prkaca Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Protein Kinase A (PKA) is a serine/threonine-specific protein kinase that functions as the catalytic subunit of the cAMP-dependent protein kinase (PKA). The PRKACA gene encodes the catalytic subunit Cα (PKA-Cα), which is one of the most important mediators of cAMP signaling in [neurons](/entities/neurons)[@skalhegg2000]. PKA plays critical roles in synaptic plasticity, memory formation, gene transcription, and neuronal survival, making it a key player in both normal brain function and neurodegenerative disease pathogenesis.

Structure

Domain Architecture

PKA catalytic subunit contains several critical structural domains:

N-terminal helix: Regulatory interaction and autoinhibitory function
Catalytic core: Kinase domain (residues 40-300) containing the active site
Glycine-rich loop: Phosphate transfer and ATP binding (residues 50-55)
Activation segment: Phosphorylation site at Thr197, required for full activity
C-terminal tail: Docking and regulatory interactions

Crystal Structure

The crystal structure of PKA has been solved in multiple conformations:

Active conformation: Bound to ATP and substrate analogs (PDB: 1J3H)
Inactive conformation: With bound inhibitors (PDB: 1J3I)
Phosphorylated form: With phosphorylated activation segment

The catalytic mechanism involves transfer of the γ-phosphate from ATP to serine/threonine residues on substrate proteins, requiring Mg²⁺ as a cofactor[@adams1992].

Normal Function

cAMP-PKA Signaling Pathway

PKA is activated by the second messenger cAMP, which is produced by adenylyl cyclase in response to neurotransmitter binding:

Receptor activation: GPCRs (e.g., dopamine D1, β-adrenergic, serotonin) couple to Gs proteins

cAMP production: Gαs activates adenylyl cyclase to produce cAMP

PKA activation: cAMP binds to the regulatory subunits of PKA, releasing catalytic subunits

Substrate phosphorylation: Free catalytic subunits phosphorylate target proteins

Signal termination: Phosphodiesterases degrade cAMP, protein phosphatases dephosphorylate targets

Neuronal Functions

PKA regulates numerous neuronal processes[@wang2003]:

| Function | Target Proteins | Effect |
|----------|-----------------|--------|
| Synaptic plasticity | GluA1, CREB, DARPP-32 | [LTP](/mechanisms/long-term-potentiation)/LTD modulation |
| Gene transcription | CREB, c-Fos | Long-term changes |
| Ion channel function | HCN, Cav1.2 | Neuronal excitability |
| Metabolism | Glycogen synthase | Energy regulation |
| Cytoskeleton | MAP2, [Tau](/proteins/tau) | Dendritic spine morphology |

Brain Regional Distribution

PKA is enriched in:

[Hippocampus](/brain-regions/hippocampus): CA1-CA3 pyramidal neurons, dentate gyrus granule cells
Cerebral [cortex](/brain-regions/cortex): Layer 2/3 and layer 5 pyramidal neurons
Striatum: Medium spiny neurons (particularly in direct pathway)
Cerebellum: Purkinje cells
Amygdala: Principal neurons

Expression Pattern

Developmental Expression

PRKACA expression is relatively constant throughout development but shows regional specificity:

Embryonic: Widespread expression in developing nervous system
Postnatal: Increased expression in forebrain regions
Adult: Highest expression in hippocampus and cerebral cortex

Cellular Localization

Cytosol: Primary location, soluble fraction
Nucleus: Translocates upon activation to phosphorylate transcription factors
Synaptic vesicles: Associated with presynaptic terminals
[Dendritic spines](/cell-types/dendritic-spines): Postsynaptic density fraction
Mitochondria: Subset localized to mitochondrial outer membrane

Role in Neurodegeneration

Alzheimer's Disease

PKA signaling is dysregulated in AD brain[@noble2005]:

cAMP-PKA axis impairment: Reduced PKA activity in AD hippocampus
CREB phosphorylation deficits: Impaired transcription of memory-related genes
[Tau](/proteins/tau) phosphorylation: PKA can phosphorylate [tau](/proteins/tau) at multiple sites (Ser214, Ser262)
Synaptic plasticity deficits: Impaired [LTP](/mechanisms/long-term-potentiation) due to PKA signaling disruption
Amyloid-β effects: [Aβ](/proteins/amyloid-beta) oligomers inhibit PKA activity

Therapeutic implications: PKA activators (e.g., phosphodiesterase inhibitors) are being explored to enhance memory in AD.

Parkinson's Disease

PKA plays complex roles in PD[^5]:

Dopamine signaling: D1 receptor-PKA pathway regulates motor control
[α-Synuclein](/proteins/alpha-synuclein) phosphorylation: PKA can phosphorylate Ser129 in α-synuclein
Mitochondrial function: PKA regulates mitochondrial dynamics and survival
L-DOPA-induced dyskinesia: Hyperactive PKA signaling contributes to LID

Therapeutic implications: PKA modulators may help manage motor complications.

Huntington's Disease

cAMP deficits: Reduced PKA activity in HD striatum
CREB dysfunction: Impaired transcription of neuroprotective genes
Mutant [huntingtin](/proteins/huntingtin-protein) effects: Interferes with PKA signaling pathways

Amyotrophic Lateral Sclerosis (ALS)

Motor neuron survival: PKA promotes motor neuron viability
Protein aggregation: PKA activity affected in ALS models
Axonal transport: PKA regulates microtubule-based transport

Therapeutic Targeting

PKA Modulators in Development

| Compound | Mechanism | Stage | Indication |
|----------|-----------|-------|------------|
| Rp-8-CPT-cAMPS | PKA inhibitor | Preclinical | Drug addiction |
| KT5720 | PKA inhibitor | Preclinical | Cancer |
| 8-CPT-2'-O-Me-cAMP | PKA activator | Preclinical | Memory enhancement |
| Forskolin | Adenylyl cyclase activator | Research | Cognitive decline |

Challenges

Broad substrate specificity: PKA phosphorylates hundreds of targets
Isoform diversity: Multiple catalytic and regulatory subunits
[Blood-brain barrier](/entities/blood-brain-barrier): Drug delivery to CNS is challenging

Alternative Approaches

Gene therapy: Targeted delivery of PKA modulators to specific brain regions
Phosphodiesterase inhibitors: Indirect PKA activation by increasing cAMP
CREB-based therapies: Target downstream effectors of PKA signaling

Research Directions

Biomarker Potential

PKA activity in CSF: Potential biomarker for synaptic dysfunction
Phospho-CREB levels: Indicator of PKA signaling integrity

Emerging Areas

PKA in glial cells: Astrocyte and [microglia](/entities/microglia) function
Circadian regulation: PKA links circadian clock to neuronal activity
Epigenetic effects: PKA-CREB axis in chromatin remodeling

Animal Models

PRKACA knockout mice: Embryonic lethal, cannot study in adult brain
Conditional knockouts: Brain-specific deletion reveals memory deficits
Transgenic overexpression: Motor phenotypes, seizure susceptibility
HD models: PKA signaling deficits contribute to phenotype

Background

The study of Prkaca Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[UniProt P17612](https://www.uniprot.org/uniprot/P17612)
[PDB: 1J3H](https://www.rcsb.org/structure/1J3H)
[Human Protein Atlas](https://www.proteinatlas.org/ENSG00000102802-PRKACA)
[KEGG Pathway: cAMP signaling](https://www.kegg.jp/kegg-bin/show_pathway?map=ko04024)

References

Unknown, Skalhegg BS, Tasken K (2000). Specificity in the cAMP/PKA signaling pathway. Advances in Second Messenger and Phosphoprotein Research. 33:1-23 (2000)

Unknown, Adams JA, Taylor SS (1992). Divalent metal ions influence catalysis and substrate accessibility in the cAMP-dependent protein kinase. Journal of Biological Chemistry. 267(10):7315-7323 (1992)

Unknown, Wang H, Storm DR (2003). Calmodulin-regulated adenylyl cyclases as computational nodes in neuronal signaling. Cell Calcium. 34(3):239-252 (2003)

Noble W, et al, (2005) (2005)

📖 View canonical wiki page →

prkaca Protein

Protein Kinase CAMP-Activated Catalytic Subunit Alpha (PKA Cα)

Introduction

Overview

Protein Kinase CAMP-Activated Catalytic Subunit Alpha (PKA Cα)

Introduction

Overview

Structure

Domain Architecture

Crystal Structure

Normal Function

cAMP-PKA Signaling Pathway

Neuronal Functions

Brain Regional Distribution

Expression Pattern

Developmental Expression

Cellular Localization

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Huntington's Disease

Amyotrophic Lateral Sclerosis (ALS)

Therapeutic Targeting

PKA Modulators in Development

Challenges

Alternative Approaches

Research Directions

Biomarker Potential

Emerging Areas

Animal Models

Background

See Also

External Links

References